Since previous results had shown that circPTPN12 accelerated sunitinib resistance of RCC cells via STAT3 pathway, we further investigated whether stattic could act as a small-molecule drug to alleviate the sunitinib resistance caused by circPTPN12 overexpression. The gene discussed is STAT3; the disease is renal cell carcinoma.